Ensign Peak Advisors, Inc Akouos, Inc. Transaction History

Ensign Peak Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.16 $53,359 - $105,898	20,523 Added 10.72%	212,036 $1.43 Million
Q2 2022 Aug 12, 2022	BUY	$2.46 - $5.2 $856 - $1,809	348 Added 0.18%	191,513 $898,000
Q4 2021 Feb 11, 2022	BUY	$7.65 - $11.38 $140,607 - $209,164	18,380 Added 10.64%	191,165 $1.63 Million
Q3 2021 Nov 12, 2021	SELL	$9.93 - $13.59 $165,364 - $226,314	-16,653 Reduced 8.79%	172,785 $2.01 Million
Q1 2021 May 12, 2021	SELL	$13.87 - $21.04 $19,237 - $29,182	-1,387 Reduced 0.73%	189,438 $2.63 Million

Q4 2020 Feb 12, 2021	SELL	$17.03 - $22.45 $271,798 - $358,302	-15,960 Reduced 7.72%	190,825 $3.78 Million
Q3 2020 Nov 12, 2020	BUY	$19.3 - $26.92 $2.35 Million - $3.28 Million	121,785 Added 143.28%	206,785 $4.73 Million
Q2 2020 Aug 12, 2020	BUY	$22.0 - $22.5 $1.87 Million - $1.91 Million	85,000 New	85,000 $1.91 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.